EOS Imaging

EOS Imaging

Paris, France· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $135M

Overview

EOS Imaging's mission is to 'connect imaging to care' by providing a foundational technology platform for orthopedic surgery. The company has achieved significant global adoption with over 500 systems installed worldwide, performing over 1 million patient exams annually. Its strategy leverages the synergistic integration of its proprietary low-dose EOS imaging hardware with its Advanced Orthopedic Solutions (AOS) software suite within the ATEC Spine ecosystem. This positions EOS not just as an imaging company, but as an integral component of a vertically aligned surgical solution aimed at improving patient outcomes and clinical efficiency.

OrthopedicsSpinal Disorders

Technology Platform

A vertically integrated platform combining proprietary low-dose, weight-bearing 2D/3D X-ray imaging hardware with the Advanced Orthopedic Solutions (AOS) software suite for 3D anatomical modeling and surgical planning.

Funding History

3
Total raised:$135M
IPO$75M
Series B$40M
Series A$20M

Opportunities

The shift to value-based care and patient-specific surgical planning creates strong demand for EOS's quantitative outcome data.
Deep integration with ATEC's spinal implant and robotics portfolio unlocks a captive sales channel and creates a differentiated, fully integrated surgical ecosystem.

Risk Factors

Execution risk in integrating with ATEC's commercial and product strategies.
High competition from large-cap medical device companies developing rival integrated planning and navigation platforms.
Sensitivity to hospital capital expenditure cycles affecting system sales.

Competitive Landscape

Competes with imaging giants (GE, Siemens) on hardware and specialized software firms (Materialise, Brainlab) on planning. As part of ATEC, its primary competitive set is now integrated spine surgery players like Medtronic, Stryker, and Johnson & Johnson, who are all building similar ecosystems of implants, planning, and robotics.